参考文献/References:
[1]郑丹翎.基于网络调查的银屑病患者危险因素比较分析[D].合肥:安徽医科大学,2020.[2]丁晓岚,王婷琳,沈佚葳,等.中国六省市银屑病流行病学调查[J].中国皮肤性病学杂志,2010,24(7):598-601.[3]龚坚,刘巧.中西医结合治疗银屑病思路与方法[J].中华中医药杂志,2021,36(7):4100-4103.[4]袁端锋,倪艳华,石岩.冰黄肤乐凝胶剂的制备及其止痒作用的研究[J].山西医药杂志,2015,44(4):454-457.[5]中华医学会皮肤性病学分会银屑病专业委员会.中国银屑病诊疗指南(2018完整版)[J].中华皮肤科杂志,2019,52(10):667-710.[6]苏蓓蓓,于建斌,张江安,等.冰黄肤乐软膏联合复方甘草酸苷治疗寻常性银屑病疗效观察[J].中国皮肤性病学杂志,2009,23(2):125-126.[7]韩春雷,彭建梅,叶笑好.冰黄肤乐软膏联合氯倍他索霜治疗寻常型银屑病临床观察[J].中国皮肤性病学杂志,2006,20(2):123-125.[8]曾建中,贾叙锋,孙华.冰黄肤乐软膏联合窄谱中波紫外线治疗寻常型银屑病的临床分析[J].中国医院用药评价与分析,2009,9(10):764-765.[9]张浩,冉玉平,眭维耻.冰黄肤乐软膏治疗寻常性银屑病临床疗效观察[J].中华皮肤科杂志,2009,42(8):587.[10]王鹏,高瑾,迪丽努尔,等.冰黄肤乐软膏治疗银屑病疗效观察[J].中国皮肤性病学杂志,2006,20(12):774-775.[11]刘涛,杜宇,陈德宇.补骨脂注射液联合冰黄肤乐软膏治疗寻常型银屑病疗效观察[J].岭南皮肤性病科杂志,2008,15(1):25-26.[12]李海燕.中药制剂治疗寻常型银屑病的临床疗效观察[J].首都医药,2010,17(24):19.[13]曹鸿玮,郑晓红,王瑞,等.冰黄肤乐软膏联合奥深软膏治疗寻常型银屑病临床疗效观察[J].四川中医,2008(11):96-97.[14]代喆,陈晓霞.冰黄肤乐软膏治疗寻常型银屑病32例[J].四川省卫生管理干部学院学报,2008,27(1):31.[15]孙亚丽,陈洪云,梁伟.冰黄肤乐软膏联合丹参注射液治疗寻常型银屑病40例[J].重庆医学,2004,33(8):1195-1202.[16]赵霞.硫黄及其制剂冰黄肤乐软膏的质量控制研究[D].北京:北京中医药大学,2020.[17]王成玉.冰黄肤乐软膏的体外抗菌活性观察[J].山东医药,2010,50(33):18.[18]刘春梅,雷佳,周志宏,等.冰黄肤乐软膏体外抗炎抗菌及皮肤毒性评价研究[J].中国医药科学,2021,11(7):1-4.
相似文献/References:
[1]郑文新,刘 红,汪 伟.银屑病易感基因的生物信息分析[J].医学信息,2018,31(21):1.[doi:10.3969/j.issn.1006-1959.2018.21.001]
ZHENG Wen-Xin,LIU Hong,WANG Wei.Bioinformatics Analysis of the Susceptible Genes of Psoriasis[J].Journal of Medical Information,2018,31(11):1.[doi:10.3969/j.issn.1006-1959.2018.21.001]
[2]李小智,丁长松,黄辛迪.基于数据挖掘的中医治疗银屑病临床用药规律研究[J].医学信息,2021,34(01):4.[doi:10.3969/j.issn.1006-1959.2021.01.002]
LI Xiao-zhi,DING Chang-song,HUANG Xin-di.Research on the Law of Clinical Use of Traditional Chinese Medicine for Psoriasis Based on Data Mining[J].Journal of Medical Information,2021,34(11):4.[doi:10.3969/j.issn.1006-1959.2021.01.002]
[3]唐 文,陈爱军.银屑病相关肾脏损害的发病机制[J].医学信息,2021,34(06):36.[doi:10.3969/j.issn.1006-1959.2021.06.010]
TANG Wen,CHEN Ai-jun.Pathogenesis of Psoriasis-related Kidney Damage[J].Journal of Medical Information,2021,34(11):36.[doi:10.3969/j.issn.1006-1959.2021.06.010]
[4]熊戌霞,蔡梦珊,吴文钦.血清鳞状细胞癌抗原在常见皮肤病中的检测价值[J].医学信息,2021,34(17):181.[doi:10.3969/j.issn.1006-1959.2021.17.050]
XIONG Xu-xia,CAI Meng-shan,WU Wen-qin.The Value of Serum Squamous Cell Carcinoma Antigen Detection in Common Skin Diseases[J].Journal of Medical Information,2021,34(11):181.[doi:10.3969/j.issn.1006-1959.2021.17.050]
[5]谢 晗,曾同祥.IL-17在常见皮肤病中的作用[J].医学信息,2021,34(23):33.[doi:10.3969/j.issn.1006-1959.2021.23.009]
XIE han,ZENG Tong-xiang.Role of IL-17 in Common Skin Diseases[J].Journal of Medical Information,2021,34(11):33.[doi:10.3969/j.issn.1006-1959.2021.23.009]
[6]任静静,石 瑛,智艳芳,等.基于生物信息学分析筛选银屑病的关键基因[J].医学信息,2022,35(24):1.[doi:10.3969/j.issn.1006-1959.2022.24.001]
REN Jing-jing,SHI Ying,ZHI Yan-fang,et al.Screening of Key Genes in Psoriasis Based on Bioinformatics Analysis[J].Journal of Medical Information,2022,35(11):1.[doi:10.3969/j.issn.1006-1959.2022.24.001]
[7]黄 永,顾礼忠.NB-UVB与白芍总苷胶囊联合用于银屑病患者治疗对免疫功能及皮损PASI评分的影响[J].医学信息,2023,36(12):148.[doi:10.3969/j.issn.1006-1959.2023.12.030]
HUANG Yong,GU Li-zhong.Effect of NB-UVB Combined with Total Glucosides of Paeony Capsule on Immune Function and PASI Score of Psoriasis Patients[J].Journal of Medical Information,2023,36(11):148.[doi:10.3969/j.issn.1006-1959.2023.12.030]